{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:32:53Z","timestamp":1772155973092,"version":"3.50.1"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/gco.0000000000000084","type":"journal-article","created":{"date-parts":[[2014,6,29]],"date-time":"2014-06-29T17:48:06Z","timestamp":1404064086000},"page":"243-252","source":"Crossref","is-referenced-by-count":28,"title":["Novel agents for the medical treatment of endometriosis"],"prefix":"10.1097","volume":"26","author":[{"given":"Lieven","family":"Platteeuw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"D\u2019Hooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis.","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","article-title":"High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners.","volume":"92","author":"Meuleman","year":"2009","journal-title":"Fertil Steril"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0015-0282(97)81391-X","article-title":"Revised American Society for Reproductive Medicine classification of endometriosis.","volume":"67","author":"Canis","year":"1997","journal-title":"Fertil Steril"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis.","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod"},{"key":"R5-5-20210129","first-page":"48","article-title":"Endometriosis in patients with chronic pelvic pain: is staging predictive of the efficacy of laparoscopic surgery in pain relief Gynecol Obstet I","volume":"62","author":"Milingos","year":"2006","journal-title":"nvest"},{"key":"R6-5-20210129","first-page":"853","article-title":"Posterior deep infiltrating endometriotic nodules: operative considerations according to lesion size, location, and geometry, during ones learning curve.","volume":"20","author":"Protopapas","year":"2014","journal-title":"ISRN Obstet Gynecol"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis.","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/humupd\/dmp007","article-title":"Recurrence of endometriosis and its control.","volume":"15","author":"Guo","year":"2009","journal-title":"Human Reprod Update"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humupd\/dmr030","article-title":"The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical afficacy studies.","volume":"17","author":"Pullen","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2353\/ajpath.2010.090757","article-title":"The immunoconjugate icon targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.","volume":"176","author":"Krikun","year":"2010","journal-title":"Am J Pathol"},{"key":"R11-5-20210129","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.","volume":"8","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1933719113497292","article-title":"Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.","volume":"21","author":"Diamond","year":"2014","journal-title":"Reprod Sci"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1210\/en.2010-1010","article-title":"Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.","volume":"152","author":"Kulak","year":"2011","journal-title":"Endocrinology"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000297307.35024.b5","article-title":"Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial.","volume":"111","author":"Stratton","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.gyobfe.2013.07.016","article-title":"Interest of selective progesterone receptor modulators in endometriosis.","volume":"41","author":"Merviel","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejps.2010.01.012","article-title":"A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies.","volume":"39","author":"Mei","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486).","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertil Steril"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/oxfordjournals.humrep.a135900","article-title":"Effects of the progesterone antagonists onapristone (ZK 98299) and ZK 136799 on surgically induced endometriosis in intact rats.","volume":"10","author":"Stoeckemann","year":"1995","journal-title":"Hum Reprod"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1477-7827-1-123","article-title":"Potential involvement of the immune system in the development of endometriosis.","volume":"2","author":"Kyama","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"issue":"1-2","key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-0378(01)00132-2","article-title":"Mechanisms of excessive estrogen formation in endometriosis.","volume":"55","author":"Bulun","year":"2002","journal-title":"J Reprod Immunol"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2013.10.007","article-title":"Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis.","volume":"172","author":"Laudanski","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/13543784.2012.683783","article-title":"New trends for the medical treatment of endometriosis.","volume":"21","author":"Rocha","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2004.02.007","article-title":"The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis.","volume":"116","author":"Cobellis","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.fertnstert.2011.05.063","article-title":"The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis.","volume":"96","author":"Olivares","year":"2011","journal-title":"Fertil Steril"},{"key":"R27-5-20210129","first-page":"119","article-title":"Anastrozole and celecoxib for endometriosis treatment, good to keep them apart R","volume":"145","author":"Olivares","year":"2013","journal-title":"eproduction"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5301\/JE.2011.8331","article-title":"Omega 3 fatty acids counteract IL-8 and prostaglandinE2 secretion induced by TNF-alpha in cultured endometrial stromal cells.","volume":"3","author":"Novembri","year":"2011","journal-title":"J Endometriosis"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2407-5-75","article-title":"Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro.","volume":"7","author":"Gustafsson","year":"2005","journal-title":"BMC Cancer"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"240702","DOI":"10.1155\/2013\/240702","article-title":"A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine.","volume":"2013","author":"Porpora","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/1933719111400635","article-title":"Remission of endometriosis by hyperbaric oxygen treatment in rats.","volume":"18","author":"Aydin","year":"2011","journal-title":"Reprod Sci"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.172.1.391","article-title":"Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectintumor necrosis factor synthesis at separate points in the signalling pathway.","volume":"172","author":"Han","year":"1990","journal-title":"J Exp Med"},{"key":"R33-5-20210129","first-page":"CD007677","article-title":"Pentoxifylline for endometriosis.","volume":"18","author":"Lu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2006-2486","article-title":"Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells.","volume":"92","author":"Takemura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/humrep\/deq016","article-title":"The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model.","volume":"25","author":"Oner","year":"2010","journal-title":"Hum Reprod"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1933719111410713","article-title":"Novel therapies targeting endometriosis.","volume":"18","author":"Taylor","year":"2011","journal-title":"Reprod Sci"},{"issue":"Suppl 3","key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2004.02.148","article-title":"Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.","volume":"82","author":"Lebovic","year":"2004","journal-title":"Fertil Steril"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/en.2009-1076","article-title":"Peroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study.","volume":"151","author":"Lebovic","year":"2010","journal-title":"Endocrinology"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.fertnstert.2012.03.004","article-title":"Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis.","volume":"97","author":"Wieser","year":"2012","journal-title":"Fertil Steril"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719112452941","article-title":"The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model.","volume":"20","author":"Ozer","year":"2013","journal-title":"Reprod Sci"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/humrep\/des150","article-title":"The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.","volume":"27","author":"Mariani","year":"2012","journal-title":"Hum Reprod"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1095\/biolreprod.105.043349","article-title":"Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study.","volume":"74","author":"DHooghe","year":"2006","journal-title":"Biol Reprod"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/humrep\/del044","article-title":"Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon.","volume":"21","author":"Falconer","year":"2006","journal-title":"Hum Reprod"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/humrep\/den177","article-title":"Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial.","volume":"23","author":"Koninckx","year":"2008","journal-title":"Hum Reprod"},{"key":"R46-5-20210129","first-page":"CD008088","article-title":"Anti-TNF- treatment for pelvic pain associated with endometriosis.","volume":"28","author":"Lu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/jcem.87.2.8260","article-title":"Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions.","volume":"87","author":"Kats","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"e37264","DOI":"10.1371\/journal.pone.0037264","article-title":"Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.","volume":"7","author":"Khoufache","year":"2012","journal-title":"PLoS One"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.atherosclerosis.2009.07.043","article-title":"Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: three clinical-grade fully human antibodies.","volume":"208","author":"Pedretti","year":"2010","journal-title":"Atherosclerosis"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/humrep\/der195","article-title":"The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.","volume":"26","author":"Schwager","year":"2011","journal-title":"Hum Reprod"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/156800905774932824","article-title":"Antiangiogenic and anti-inflammatory effects of statins: relevance to anticancer therapy.","volume":"5","author":"Dulak","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2004.06.080","article-title":"Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane.","volume":"83","author":"Nap","year":"2005","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.fertnstert.2005.04.040","article-title":"Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.","volume":"84","author":"Becker","year":"2005","journal-title":"Fertil Steril"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jc.2003-031406","article-title":"Antiangiogenesis therapy for endometriosis.","volume":"89","author":"Nap","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-5-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0002-9440(10)64251-4","article-title":"Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis.","volume":"161","author":"Dabrosin","year":"2002","journal-title":"Am J Pathol"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2353\/ajpath.2006.051133","article-title":"A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.","volume":"168","author":"Becker","year":"2006","journal-title":"Am J Pathol"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.rbmo.2009.11.004","article-title":"Atorvastatin causes regression of endometriotic implants in a rat model.","volume":"20","author":"Yilmaz","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/del505","article-title":"High-dose atorvastatin causes regression of endometriotic implants: a rat model.","volume":"22","author":"Oktem","year":"2007","journal-title":"Hum Reprod"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2008-2802","article-title":"Simvastatin protects against the development of endometriosis in a nude mouse model.","volume":"94","author":"Bruner-Tran","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1196\/annals.1434.008","article-title":"Endometriosis and tissue factor.","volume":"1127","author":"Krikun","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"R61-5-20210129","first-page":"109","article-title":"Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice.","volume":"34","author":"Yoysungnoen","year":"2006","journal-title":"Clin Hemorheol Microcirc"},{"key":"R62-5-20210129","first-page":"87","article-title":"Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis.","volume":"27","author":"Zhang","year":"2011","journal-title":"Int J Mol Med"},{"key":"R63-5-20210129","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1210\/jc.2002-021912","article-title":"Antiangiogenic agents are effective inhibitors of endometriosis.","volume":"88","author":"Hull","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.fertnstert.2009.04.042","article-title":"Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirus.","volume":"93","author":"Rein","year":"2010","journal-title":"Fertil Steril"},{"key":"R65-5-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/humrep\/den499","article-title":"Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.","volume":"24","author":"Novella-Maestre","year":"2009","journal-title":"Hum Reprod"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation.","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"R67-5-20210129","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/REP-11-0223","article-title":"The effects of ergot and nonergot-derived dopamine agonists in an experimental mouse model of endometriosis.","volume":"142","author":"Delgado-Rosas","year":"2011","journal-title":"Reproduction"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.fertnstert.2010.10.024","article-title":"Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia.","volume":"95","author":"Gomez","year":"2011","journal-title":"Fertil Steril"},{"key":"R69-5-20210129","first-page":"71","article-title":"Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endomtriosis that is still at large Gynecol Obstet I","volume":"63","author":"Guo","year":"2007","journal-title":"nvest"},{"key":"R70-5-20210129","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/humrep\/den246","article-title":"Combating endometriosis by blocking proteasome and nuclear factor-B pathways.","volume":"23","author":"Celik","year":"2008","journal-title":"Hum Reprod"},{"key":"R71-5-20210129","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ajpath.2011.04.020","article-title":"The mTORAKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.","volume":"179","author":"Leconte","year":"2011","journal-title":"Am J Pathol"},{"issue":"1-2","key":"R72-5-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jri.2005.02.004","article-title":"FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model.","volume":"72","author":"Yoshino","year":"2006","journal-title":"J Reprod Immunol"},{"key":"R73-5-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/molehr\/gaq090","article-title":"Pyrrolidine dithiocarbamate inhibits nuclear factor-B pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells.","volume":"17","author":"Zhang","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"R74-5-20210129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.fertnstert.2013.06.028","article-title":"Parthenolide reduces cell proliferation and prostaglandin E2 corrected in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.","volume":"100","author":"Takai","year":"2013","journal-title":"Fertil Steril"},{"key":"R75-5-20210129","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2741\/E669","article-title":"Epigenetic aberration of gene expression in endometriosis.","volume":"5","author":"Izawa","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"R76-5-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/molehr\/gap064","article-title":"Epigenetics of endometriosis.","volume":"15","author":"Guo","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"R77-5-20210129","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.fertnstert.2008.04.012","article-title":"Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.","volume":"91","author":"Wu","year":"2009","journal-title":"Fertil Steril"},{"key":"R78-5-20210129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/humrep\/dep472","article-title":"Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice.","volume":"25","author":"Lu","year":"2010","journal-title":"Hum Reprod"},{"key":"R79-5-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1933719111424453","article-title":"Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats.","volume":"19","author":"Liu","year":"2012","journal-title":"Reprod Sci"},{"key":"R80-5-20210129","first-page":"CD006568","article-title":"Chinese herbal medicine for endometriosis.","volume":"16","author":"Flower","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R81-5-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2012.11.019","article-title":"Effect of human interferon-alpha-2b on experimental endometriosis in rats: comparison between short and long series of treatment.","volume":"167","author":"Ingelmo","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R82-5-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0015-0282(02)03330-7","article-title":"Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial.","volume":"78","author":"Acien","year":"2002","journal-title":"Fertil Steril"},{"key":"R83-5-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000270901","article-title":"Treatment of endometriosis with transvaginal ultrasound-guided drainage and recombinant interleukin-2 left in the cysts: a third clinical trial.","volume":"69","author":"Acien","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"R84-5-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.srhc.2012.02.001","article-title":"Pertubation with lidocaine - a nonhormonal, long-term treatment of dysmenorrhea due to endometriosis.","volume":"3","author":"Edelstam","year":"2012","journal-title":"Sex Reprod Healthc"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0000000000000084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:27:42Z","timestamp":1649503662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201408000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0000000000000084","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718490063.793497214","asserted-by":"object"}]},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}